$CMPX 8-K SEC Filings

Filed On	Filing
22 Sep 2026	8-K: Regulation FD Disclosure BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today...
06 Aug 2026	8-K: Results of Operations and Financial Condition
01 Jul 2026	8-K: Regulation FD Disclosure
23 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
11 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
05 May 2026	8-K: Results of Operations and Financial Condition
27 Apr 2026	8-K: Regulation FD Disclosure; Other Events
05 Mar 2026	8-K: Results of Operations and Financial Condition
06 Jan 2026	8-K: Results of Operations and Financial Condition; Other Events
05 Nov 2025	8-K: Results of Operations and Financial Condition
13 Aug 2025	8-K: Entry into a Material Definitive Agreement; Other Events
11 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
01 Apr 2025	8-K: Regulation FD Disclosure; Other Events
27 Feb 2025	8-K: Results of Operations and Financial Condition
08 Jan 2025	8-K: Results of Operations and Financial Condition; Other Events
10 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
12 Nov 2024	8-K: Results of Operations and Financial Condition
12 Aug 2024	8-K: Results of Operations and Financial Condition

Comments